NNOX: Nano-X EV/EBITDA Multiple

Corporate emblem and logo of Nano-X (NNOX)

The market price visualization for Nano-X Imaging Ltd. (NNOX) demonstrates an EV/EBITDA of 0.00, which correlates with monetization via cloud software and a pay-per-scan model. The business relies on the diversification of component suppliers to minimize electronics supply chain disruptions. Furthermore, Nano-X Imaging Ltd. (NNOX) is implementing energy-efficient tomography technologies, completely eliminating toxic reagents from its devices.

Nano-X Imaging Ltd - NNOX Enterprise Value to EBITDA Ratio (period 11/23/2025 - 11/14/2026)

Summary analytical data breakdowns for nanox.vision (NNOX)

- stock price and consensus target price:
Stock Quotes Nanox|NNOX - Analyst Forecast Prices
- market capitalization information:
Market Capitalization Nano-X Imaging Ltd|NNOX - Company Buyout Price
- issuer book value statistics:
Book Value per Share Nano-X|NNOX - Company Net Assets|Market Cap to Net Assets Ratio nanox.vision|NNOX - Aggregate Asset Value
- company liabilities and liquidity data:
Debt to Equity Nano-X Imaging Ltd.|NNOX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Nano-X|NNOX - Company Cumulative Debt|Debts to Book Capitalization Nano-X Imaging Ltd|NNOX - Company Long-Term Indebtedness|Company Short-Term Debts Nano-X|Quick Ratio nanox.vision
- financial results and valuation multiples details:
NNOX - Net Income|Projected Future Earnings Nano-X Imaging Ltd.|NNOX - P/E Multiple|Future Price to Earnings Nano-X Imaging Ltd.|NNOX - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Nano-X Imaging Ltd|NNOX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Nano-X|NNOX - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months nanox.vision|NNOX - Net earnings per share change in current year|Expected earnings per share growth for next year Nano-X Imaging Ltd.
- sales and revenue data:
NNOX - Revenue and Sales Volume|Projected Sales Volume Nanox|NNOX - Price-to-Revenue Coefficient|Price-to-Projected Revenue Ratio Nano-X Imaging Ltd
Initial company analysis:Nanox NNOX
Original product of nanox.vision

This metric serves as a fundamental benchmark for determining the fair value of assets with high debt loads. It relates the total enterprise value to its operating profit before depreciation and taxes, revealing the actual efficiency of the business. By analyzing the EV/EBITDA ratio of a capital-intensive business, an investor can track the dynamics of market expectations between quarterly reports. This is critical for Nano-X Imaging Ltd. (NNOX), as production outsourcing increases dependence on external vendors.

Competitor analysis for Nano-X Imaging Ltd.

Abbott Laboratories Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio TMO (Thermo Scientific)|GE HealthCare - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio mt.com MTD|WAT: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Bio-Techne Corp|Enterprise Value to EBITDA Ratio BRKR|AZTA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Varex Imaging (VREX)|Enterprise Value to EBITDA Ratio semlerscientific.com SMLR|EV/EBITDA Multiple BFLY (Butterfly Network)|Mesa Laboratories Inc (MLAB) - Company Value to EBITDA|Quantum-Si Corp - EV/EBITDA Multiple|QTRX (Quanterix Inc) - Enterprise Value to Operating Income Before Depreciation|MASS: EV/EBITDA Multiple|CV - Total Company Value to Operating Income Before Depreciation Ratio|MXCT (MaxCyte) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Rapid Micro (RPID)|EV/EBITDA Multiple SEER|EV/EBITDA Multiple Hyperfine Medical (HYPR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization FONAR Corporation FONR|Daxor Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MDAI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation VIVS (Organovo Holdings)|ACON: EV/EBITDA Multiple|Company Value to EBITDA Akoya Biosciences, Inc. (AKYA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ThermoGenesis|TLIS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio TTOO (T2 Biosystems)